A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to IV mCPP
- 1 January 1993
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 33 (1), 3-14
- https://doi.org/10.1016/0006-3223(93)90272-f
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Serotonergic Function in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1992
- Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chloro-phenylpiperazine in obsessive-compulsive disorderPsychiatry Research, 1991
- m-CPP: a tool for studying behavioural responses associated with 5-HT1c receptorsTrends in Pharmacological Sciences, 1990
- 1-(m-Chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brainBiological Psychiatry, 1989
- Clomipramine in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1989
- Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder: behavioral findingsAmerican Journal of Psychiatry, 1988
- Serotonin Function in Obsessive-Compulsive DisorderArchives of General Psychiatry, 1988
- The Influence of Ritanserin, a Serotonin Antagonist, in Anxiety Disorders: A Double-blind Placebo-controlled Study versus LorazepamPharmacopsychiatry, 1985
- Effects of methergoline on central monoamine neurones. Evidence for a selective blockade of central 5-HT receptorsNeuroscience Letters, 1975
- 1-Methyl-8 β-carbobenzyloxy-aminomethyl-10 α-ergoline, a Potent and Long-lasting 5-Hydroxytryptamine AntagonistNature, 1965